New York University Cancer Cen is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
New York University Cancer Cen has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Early Breast Cancer.
Sponsors: Hoffmann-La Roche, Genentech, Inc..
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York University Cancer Cen has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York University Cancer Cen has 4 clinical trials on record, with 2 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Early Breast Cancer.
New York University Cancer Cen has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.